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Abstract: 
Aim: To assess the effects of oleic acid treatment on subcellular distribution of indium gallium 
phosphide–zinc sulfide (InGaP/ZnS) nanoparticles in microglia and astrocytes. Materials & 
methods: The extent of colocalization between the nanoparticles and organelles was assessed by 
confocal microscopy, spectrofluorometry and cell sorting. Results: Cell treatment with a 
common fatty acid (oleic acid) within the range of physiological concentrations markedly 
enhanced the InGaP/ZnS uptake by microglia and afforded their colocalization within lipid 
droplets/lysosomes but not with mitochondria. Conclusion: These results suggest that the 
availability of mono-unsaturated fatty acids, such as oleic acid, in different cells could 
significantly alter nanoparticle uptake and localization, which can in turn affect the functions of 
cells and tissues coexposed to nanoparticles. 
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Article: 
One of the challenges in nanomedicine is the determination of the distribution of nanoparticulate 
carriers and nanoparticles in the body, as well as in individual cells, in real time [1] . Most of the 
single cell studies performed to date were done in different cell lines, but studies in primary 
neural cultures are still relatively sparse [2-6] . The main objective of the present study was to 
examine the intra-organelle distribution of indium gallium phosphide-zinc sulfide (InGaP/ZnS)-
coated nanoparticles in primary neural glial cells obtained from the cortical brain region, and to 
assess the role of exogenous oleic acid as a putative agent that can influence nanoparticle 
subcellular distribution. The rationale for selecting InGaP/ZnS nanoparticles is that they have 
excellent photophysical properties and they are less toxic within a low nanomolar concentration 
range (1-10 nM) than several other nanoparticles [7,8] . Primary cortical-dispersed mixed culture 
systems and microglia N9 cells were used to examine uptake and subcellular distribution of 
InGaP/ZnS nanoparticles in various cell types of the CNS and to find out how cell treatments 
with oleic acid can alter their distribution. 
Oleic acid is a monounsaturated fatty acid (C18:1), one of the most common fatty acids present 
in mammalian tissues and a common component of various foods (e.g., olive oil). Oleic acid is 
produced by astrocytes in the brain [9-11] , and is utilized by neurons, particularly during nervous 
system development [12] . Interestingly, it has also been used as a component of different 
pharmaceutical preparations such as gels [13] , nanoparticles [13-16] and transdermal drug 
penetration enhancers [17-19] . It was suggested that oleic acid can be employed as an ion-pairing 
agent to facilitate transfer across lipoidal membranes [20] but others attribute this enhancement to 
the cis -structure of oleic acid, which disrupts lipid bilayers when applied to the skin's 
surface [21] . In addition, in cultured human hepatocytes, oleic acid was found to induce lipid 
droplet formation [22] . Lipid droplets are organelles that have been extensively studied in adipose 
tissues, but not in the CNS. Lipid droplets were detected in brain glioma cells but their function 
still remains unclear [23] . Lipid droplets are intracellular neutral lipid-storage sites that can also 
interact with other organelles [24,25] . The functional significance of lipid droplet interactions with 
different organelles is not clear; it appears that they provide fuel to mitochondria and could alter 
the transfer of phospholipids, cations and signaling proteins. Functional roles of lipid droplets in 
cells exposed to nanoparticles were not previously explored and are currently unknown. 
In this study, we examined the uptake and colocalization of (negatively charged 
mercaptohexadecanoic acid [MHDA]) InGaP/ZnS nanoparticles in primary cortical cultures and 
microglia N9 cells. We further investigated whether the induction of lipid droplets in the 
presence of oleic acid will alter the InGaP/ZnS nanoparticle subcellular distribution. So far, there 
are no reports examining lipid droplet-nanoparticle colocalization in glial cells. The rationale for 
focusing on glia in this study is that astroglia and microglia are most likely the major players in 
retaining and delivering nanoparticles in the CNS [26,27] . The delivery of therapeutic agents and 
diagnostic compounds to specific brain regions is restricted by several barriers including the 
blood-brain barrier, the blood-cerebrospinal fluid barrier and other specialized barriers. 
Strategies to advance translational research into brain barriers was recently reviewed by 
Neuwelt et al. and recommendations to advance the research in this area have been proposed [28] . 
Several imaging and drug-delivery strategies to brain tumors have been developed [29,30]and new 
nanomedicines are in clinical trials for glioblastomas. 
Several groups, including our laboratory, have demonstrated that metallic and other 
nanoparticles are taken up by microglia, macrophages of the nervous system [31,32] . Glial cells, 
astrocytes and especially microglia, avidly respond to various insults to the nervous 
system [33] and play a critical role in the functioning of the CNS at all stages of life, under both 
normal and pathological conditions [34,35] . In addition, microglia constitute a critically important 
'surveillance cell network' in the nervous system. They are highly dynamic and upon focal 
activation they switch from a patrolling to a shielding mode. Time-lapse experiments showed 
microglia processes as remarkably motile, with processes contacting neurons and astrocytes [36] . 
Brain astrocytes are activated by some, but not all, nanoparticles, as shown by real-time imaging 
in mice [31] . In the current study we show that microglia are the major glial cell type that 
internalize InGaP/ZnS nanoparticles in mixed primary cortical cultures. In addition, we show 
that the distribution and uptake of InGaP/ZnS nanoparticles within individual organelles 
(lysosomes, mitochondria and lipid droplets) are markedly affected in neural cells exposed to 
oleic acid. 
Materials & methods 
* Nanomaterials & vital dyes 
InGaP/ZnS (Evident Technologies Troy, NY) nanoparticles are functionalized with hydrophobic 
ligands such as trioctyl-phosphine oxide, therefore soluble only in organic solvent. To render 
them soluble in aqueous solution for application in biological media, the trioctyl-phosphine 
oxide capping groups were exchanged with MHDA; these InGaP/ZnS nanoparticles were 
characterized as previously described [8] . The InGaP nanoparticles are coated with ZnS, have an 
overall negative surface charge, have a core size of 5 nm and emit at 680 nm. Stock solutions of 
InGaP/ZnS nanoparticles were diluted in Neurobasal A cell culture medium to yield 1-10 nM 
working concentrations. 
Some of the critical physical and photophysical properties of these and other employed 
nanoparticles in this study are summarized in Table 1. The cadmium telluride (CdTe) 
nanoparticles are not coated with ZnS; they have mercaptopropionic acid and an overall negative 
charge (-9.6 mV) with an emission wavelength at 535 nm and a core size of 2.8 nm. Similar 
nanoparticles were described previously [3] . Two types of cadmium selenide (CdSe) 
nanoparticles were used: those coated with ZnS and capped with mercaptopropionic acid (core 
size 4.3 nm) and those with polyethylene glycol (PEG) with a hydrodynamic radius of 18-20 nm. 
These PEGylated CdSe nanoparticles have neutral surfaces and an emission wavelength 
maximum at 705 nm (Invitrogen, Ontario, Canada). Additional details of cores and surfaces are 
discussed in the section 'Results & discussion'. 
Vital dyes used for labeling cellular organelles were purchased from Invitrogen. Lysosomes were 
visualized with LysoTracker green DND-26 (0.5 µM, 3 min; &lambda;ex 504 nm, 
&lambda;em 511 nm). Mitochondria were stained in cortical primary cultures with MitoTracker 
Green FM (0.5 µM; 3 min; &lambda;ex 490, &lambda;em 516 nm). Lipid droplets were visualized 
with Bodipy 493/503 (0.01 mg/ml, 3 min; &lambda;ex 493 nm, &lambda;em 503 nm). 
* Cell cultures & treatments 
Dissected cortices of mice (129T2/SV, postnatal day 5, from at least six animals), were freed 
from meninges, pooled and stored into ice-cold sterile Ca2+ /Mg2+ free phosphate-buffered saline 
(PBS; Invitrogen). Small pieces were dissociated mechanically by gentle trituration using sterile 
1 ml pipette tips (Fisher, Montreal, Quebec, Canada) and trypsinized with 0.25% 
trypsin/ethylenediaminetetraacetic acid (15050-15065, Invitrogen) at 37°C for 10 min. 
Dissociated cells were resuspended in Dulbecco's Modified Eagle Medium (11995-11073, 
Invitrogen) containing 10% fetal bovine serum (26140-26079, Invitrogen) and 
penicillin/streptomycin/neomycin cocktail (15640-15055, Invitrogen). Cells in suspension were 
seeded onto poly-L-ornithine (P-3655, Sigma, Ontario, Canada) and laminine (L-2020, Sigma)-
coated 12-mm glass cover slips (12-545-580, Fisher) and incubated in a 95% air/5% 
CO2 atmosphere at 37°C. Attached cells were placed in DMEM medium plus supplements for 24 
h in 24-well plates (Corning plates from Fisher). The next day, cells were washed twice with 
prewarmed Neurobasal A media (12349-12015, Invitrogen) and, finally, serum-free Neurobasal 
A medium containing B27 (17504-17044, Invitrogen), l-glutamine (G-7513, Sigma) and 
penicillin/streptomycin/neomycin supplements. The cultures were maintained in 95% air/5% 
CO2 atmosphere at 37°C. The cells were used for experiments at in vitro day 8, treated with oleic 
acid (400 µM complexed with bovine serum albumin, Sigma; 24 h) and then treated with 
InGaP/ZnS nanoparticles (6 × 1012 nanoparticles/ml) in the presence of oleic acid for 4-72 h. 
Control cells received only the equivalent volume of the cell culture medium used for cell 
treatment with nanoparticles. All measurements were performed in triplicate in at least two 
independent experiments. 
* Uptake of nanoparticles by flow cytometric analysis (fluorescence-activated cell sorting) 
Microglia cells grown in Iscove's Modified Dulbecco's Medium and PC12 cells cultured in 
Roswell Park Memorial Institute (RPMI) medium 1640 phenol-red free medium containing 10% 
fetal bovine serum in 24-well plates were used 24-48 h after plating. 24 h after incubation with 
nanoparticles (Table 1, CdTe, CdSe, InGaP), all cells were exposed to 1-10 nM nanoparticle 
concentrations for 4 and 24 h, cells were washed twice in PBS and detached by vigorous 
shaking. Cells were centrifuged at 2500 rpm for 6 min, resuspended in cold PBS with 1% bovine 
serum albumin and finally placed on ice before the analysis. Flow cytometric analysis was done 
with a triple-laser flow cytometer (BD FACS[trademark] Area, Becton-Dickinson, CA, USA) 
and data analysis was performed using the Flowjob Treestar Software (Ashland, Oregon, USA). 
For detection of nanoparticle emission at 535, excitation was done at 488 nm (blue laser) and the 
emission was determined by a dichroic 530/30/FITC bandpass filter. For CdSe/ZnS PEG 
nanoparticles and InGaP nanoparticles, optimal excitation was achieved with 633 nm laser and a 
660/40 nm bandpass filter. The median of measured fluorescence was used to calculate the 
relative uptake of nanoparticles relative to controls that were not exposed to any nanoparticles 
but received an equivalent volume of the corresponding cell culture media. All experiments were 
performed in triplicate. Fluorescent signal from 5000 or 10,000 cells was collected and expressed 
as mean fluorescence intensity (MFI). MFI is the arithmetic mean of the data; the linear-scaled 
fluorescence values are averaged and the result is weighted by outliers at the high end of the 
distribution. Measurements were done at least twice and values are averages of at least six 
measurements (n = 6). Results were analyzed by analysis of variance (ANOVA). 
* Confocal microscopy 
Cells were grown on 12 mm2 glass cover slips (2 × 105 cells/well) in 24-well chambers (Sarstedt, 
Montreal, Quebec, Canada) and InGaP/ZnS nanoparticles were added to designated wells. The 
cells were incubated for different time periods with individual vital dyes to visualize organelles. 
Live imaging was carried out on a Leica SP2 confocal microscope. Double- and triple-labeled 
samples were imaged for colocalization. Images were obtained by sequential imaging to prevent 
bleed-through. All images were taken using a HCXPLAPO 63X lens. 
Before imaging, cells were washed with PBS or with serum-free medium. No background 
fluorescence was detected in cells under the settings used. Images were acquired at a resolution 
of 512 × 512 and 1024 × 1024. The scan size was 146.2 × 146.2 µm. The images were averaged 
four times to improve the signal:noise ratio with a Z-section of 0.25 µm. Images were transferred 
to Imaris software (Bitplane Ag, Switzerland[101] ) for 3D visualization and colocalization 
quantification studies. As a negative control we performed colocalization studies on glial 
fibrillary acidic protein and Hoechst 33342 (for labeling cell nuclei), which do not colocalize. 
Lysosomes were visualized with LysoTracker green DND-26, (0.5 µM, 3 min); &lambda;ex 504 
nm, &lambda;em 511 nm). Mitochondria were stained with MitoTracker Green FM, (0.5 µM; 3 
min; &lambda;ex 490, &lambda;em 516 nm) and lipid droplets were visualized with Bodipy 
493/503 (0.01mg/ml, 3 min, &lambda;ex 493 nm, &lambda;em 503 nm). Figures were created 
using Adobe® Photoshop and Microsoft Office® PowerPoint 2003. 
* Colocalization measurements 
The extent of colocalization of the two labels (i.e., InGaP/ZnS nanoparticle and organelle-
specific fluorescent dye) was measured using the 'colocalization' module of Imaris, 64-bit 
version (Bitplane AG) [37] . This program allows the analysis of stacks of confocal sections 
obtained in two channels. Each of the confocal sections consists of an array of square elements 
called pixels. A voxel is defined from a pixel as a prism in which the base is the pixel and the 
height is the thickness of the confocal section. 
The Imaris Colocalization module is used to determine the intensity threshold of the dynamic 
range (in the 0-255 scale of pixel intensity) for each of the two labels [38] . Any voxels with 
intensities above this threshold are considered to be above the background noise. In the software, 
a voxel is defined as having colocalization when the intensities of both labels are above their 
background thresholds. The program has an automatic threshold feature to avoid investigators' 
bias in setting the threshold [38] . 
The data from this produces a colocalization measure for each of the labels. This method may 
lead to an overestimate in the amount of colocalization, as the disadvantage is that it does not 
reflect whether the intensities of the two labels increase and decrease together in the same 
voxels, whereas when there is a high degree of colocalization the intensities of the two labels 
would be expected to vary together. We also used the Pearson coefficient in voxels with 
colocalization. The Pearson coefficient is a number between +1 and -1, with positive values 
indicating a direct correlation, negative values indicating an inverse correlation and values near 0 
indicating no correlation. Negative values of the Pearson coefficient are seldom encountered in 
colocalization studies. In this case, the Pearson coefficient measures the correlation between the 
intensities of the two labels only in the voxels with colocalization. This measure is more precise 
than 'the percentage of material colocalized,' as it has an additional requirement that the 
intensities of the two labels vary together, but the Pearce coefficient may underestimate the 
amount of colocalization [37] . 
The following procedure was used to measure colocalization. A computer folder containing the 
stack of confocal sections for the two labels was generated by the Leica SP2 confocal 
microscope. A region of interest was defined as all the voxels in which the intensity of one of the 
labels was above a pixel intensity of 10 (in the dynamic range 0-255 scale). A pixel intensity of 
10 was well within the background for all images. We then used the automatic threshold to 
calculate the thresholds for each label. Threshold values varied between pixel intensities of 10 
and 95, and generally agreed with background levels estimated visually. Once the thresholds 
were set, the program was able to output the measures of colocalization as described previously. 
* Statistical analysis 
Data were analyzed using SYSTAT 10 (SPSS, Chicago, IL, USA). Statistical significance was 
determined by Student's t-test, one-way ANOVA followed by multiparametric Dunett's post 
hoc test, or two-way ANOVA. Differences were considered significant where p was less than 
0.05. 
Results & discussion 
The purpose of this study was to explore subcellular distribution of InGaP/ZnS nanoparticles in 
glial cells and to examine whether the cell treatment with a common fatty acid (oleic acid) can 
alter nanoparticle uptake and distribution in organelles of glial cells. 
Results from these studies show that nanoparticles made of elements from group III/V, such as 
InGaP/ZnS, can be readily detected in primary living glial cells; InGaP/ZnS nanoparticles are 
distributed in several organelles, including lipid droplets, induced by oleic acid and in its 
presence; uptake of InGaP/ZnS nanoparticles and their subcellular distribution is markedly 
enhanced by oleic acid treatment. This organelle was not previously studied in the context of 
nanoparticle distribution in living cells of the CNS. 
We first tested several fluorescent nanoparticles (Table 1) to select the ones with best-suited 
photophysical properties for subcellular distribution studies by confocal microscopy. These 
nanoparticles can be excited within a wide range of wavelengths and have relatively narrow 
fluorescence maxima. Their core components (CdTe, CdSe, InGaP) and sizes are different. 
InGaP/ZnS nanoparticles (type III-V core elements), CdTe and CdSe nanoparticles (type II-VI) 
had negative surfaces. Commercially available CdSe/ZnS nanoparticles coated with PEG were 
recently presented as promising tools for multicolor bioimaging [2,31] . In particular, 
CdSe/ZnS/PEG nanoparticles emit near-infrared light (core size: 2.6 nm; hydrodynamic radius: 
18-20 nm; emission at 705 nm) with minimal or no tissue background autofluorescence and have 
excellent photostability. They have neutral surfaces, due to the methoxy terminal on the PEG 
polymer. As such, they were designed to decrease nonspecific adhesion properties and to reduce 
their heavy metal-induced cell death. Nevertheless, II-VI nanoparticles still contain heavy metal 
core elements (cadmium, selenium) and thus possess a potential risk for inducing cytotoxicity in 
a concentration-time-dependent manner, due to the initiation of unspecific cellular degradation 
processes [39] . Similarly, CdTe nanoparticles without a ZnS coating with overall negative surface 
charge, due to the carboxylate terminal group from mercaptopropionic acid, are poorly 
fluorescent. These nanoparticles were prepared and characterized as described in the previous 
study [40] and discussed in [39] . They are prone to degradation and cadmium release in biological 
media [41,42] . To overcome this limitation we employed InGaP/ZnS nanoparticles (core size: 5.0 
nm; emission at 680 nm), which appeared to be good candidates for live cell and ex vivo imaging 
with desirable photophysical properties [8] . InGaP/ZnS nanoparticles capped with MHDA have 
an overall negative surface charge, owing to the carboxylate terminal group. PEGylated 
InGaP/ZnS nanoparticles with a negative surface charge are now commercially available 
(eFluoro 700 [Carboxyl]; emission: 703.5 nm; quantum yield: 30%, using reference dye 
Rhodamine 6G) and they compare favorably to those described previously [8] . The initial 
internalization studies were performed with all three negatively charged nanoparticle types using 
fluorescence-activated cell sorting analysis and two different cell lines (Figure 1). 
Pheochromocytoma, PC12 cells are well characterized and frequently used in vitro as a model 
system in basic neuroscience research. The mouse microglia are phagocytic cells in the CNS. 
FIGURE 1 IS OMITTED FROM THIS FORMATTED DOCUMENT 
Figure 1. Uptake of nanoparticles in living PC12 cells and microglia. 
(A) Uptake of nanoparticles in PC12 cells and (B) microglia N9 determined by fluorescence-activated cell 
sorting analysis. (C) Live cell imaging of InGaP/ZnS nanoparticles compared with CdSe/ZnS-PEG and 
CdTe nanoparticles in PC12 cells. All cells were treated with nanoparticles under comparable conditions 
(10 nM, for 4 h). (1-3) are control cells not exposed to any quantum dots. (4-6) are cells treated with 
CdTe, CdSe/ZnS-PEG and InGaP/ZnS quantum dots. All measurements were done in triplicate in at least 
two independent experiments. Scale bar = 5 µm. 
Results from these studies showed that the MFI in PC12 cells treated with cadmium telluride 
nanoparticles was very low and indistinguishable from the autofluorescence of the cells. 
CdSe/ZnS nanoparticles with the same surface (mercaptopropionic acid, net negative charge) and 
the PEGylated ones with the same cores could be barely detected in the low nanomolar 
concentration range (0.1-1 nM), but MFI was significantly higher with treatments in the 10 nM 
concentration (Figure 1). By contrast, InGaP/ZnS nanoparticles were detectable in cells even in 1 
nM concentration and the MFI was significantly higher compared with other nanoparticles in the 
10 nM concentration (p < 0.05). The MFI value for 10 nM InGaP/ZnS nanoparticles was 875.05 
± 41.69. Similar trends in relative fluorescence intensity values were observed in living N9 
microglia cells treated with the equivalent (10 nM) InGaP/ZnS nanoparticles for 4 h (Figure 1B). 
Spectrofluorometric determinations of internalized nanoparticles yielded similar results 
confirming that InGaP/ZnS nanoparticles are the most promising tools for imaging and 
subcellular distribution studies (not shown). Preliminary measurements of internalized 
concentrations of InGaP/ZnS nanoparticles at different times after the initial exposure showed 
InGaP/ZnS in approximately 2 nM cytoplasmic concentration after 4 h of exposure. The 
concentration increased (4.3-5.0 nM) after 10-12 h and did not significantly increase after 24 h 
(5.3-5.9 nM). These data are consistent with internalization mechanisms for CdSe/ZnS quantum 
dots recently suggested by Zhang [41] . 
Fluorescent microscopy (Figure 1C) analyses further confirmed that the strongest fluorescent 
signal was observed with InGaP/ZnS nanoparticles (Figure 1C, panel 6; the top panels 1, 2 and 3 
correspond to control cells without nanoparticle treatment but with only 30 µl of cell culture 
media added. Panels 4, 5 and 6 show cells treated with nanoparticles dispersed in 30 µl). On 
average 150-200 cells were analyzed per condition. Typical appearances of single cells 
containing fluorescent nanoparticles (bottom panels) and their corresponding controls (without 
nanoparticle treatment, top panels) are shown. Some PC12 and microglia N9 cells did not 
internalize nanoparticles, regardless of the time of exposure (1-3 days) and within 1-10 nM 
concentrations. A strong signal (panel 6) from the internalized InGaP/ZnS nanoparticles 
suggested the existence of aggregated nanoparticles (notice a punctate distribution of InGaP/ZnS 
nanoparticles in the cytoplasm but not in the nucleus). Carboxylic groups found at the terminal 
end of the capping ligand add coulombic repulsion to sterically protect the nanoparticles. 
Therefore, the loss of the hydrophilic MHDA capping ligand can induce aggregation of bare 
InGaP/ZnS nanoparticles [43] . In addition, the smallest change in pH may cause aggregation in 
the cytoplasm due to the high affinity between nanoparticles [44] . Neither InGaP/ZnS 
nanoparticles nor CdSe/ZnS nanoparticles were blinking, suggesting intracellular nanoparticle 
aggregates. 
In order to determine more precisely the intracellular localization sites of InGaP/ZnS 
nanoparticles in different organelles, confocal microscopy was performed and z-stacks from 
individual cells from the primary cortical cultures were analyzed. These cortical cells in primary 
cultures consist of several different cell types, including different glial cells and neurons. 
Initially, for in vitro cortex imaging, primary neural cerebral cultures from 5-day-old mice were 
characterized by immunostaining using specific antibodies to identify glial cells and neurons 
(Figure 2). Most of the cells were astrocytes (>70%) as revealed by antibodies recognizing glial 
fibrillary acidic protein; relatively smaller populations were neurons (10-15% were [beta]-III 
tubulin positive cells) and microglia (<10% cells were Iba-1 and Mac-2 positive). 
Primary cultures were maintained for 7 days in vitro prior to being treated with InGaP/ZnS 
nanoparticles and analyzed by confocal fluorescent microscopy. This approach allowed for the 
generation of z-stacks and a closer look at nanoparticle localization in association with the 
plasma membrane and intracellular localizations. The localization of the InGaP/ZnS 
nanoparticles within glial cells and intracellular organelles was performed in live cells using 
selected vital dyes for mitochondria and acidic organelles. 
FIGURE 2 IS OMITTED FROM THIS FORMATTED DOCUMENT 
Figure 2. Immunostained neural cells in primary cortical mouse dispersed cultures. 
(A) GFAP-positive cells (astrocytes); (B) [beta]-tubulin (neurons); (C) Iba-1- and Mac-2-positive 
microglia. All pictures were taken with 20×. 
GFAP: Glial fibrillary acidic protein. 
Since microglia are the major nanoparticle 'consumers', we immunolabelled astrocytes and 
microglia (green) and assessed whether InGaP/ZnS nanoparticles were taken up by both 
astrocytes and microglia, or preferentially one glial cell type (Figure 3). Immunostaining with 
antibodies specific for astrocytes (Figure 3A-C) and microglia (Figures 3D-F) showed that 
InGaP/ZnS nanoparticles were largely taken up by microglia (Figures 3E & F). In addition, cell-
sorting analysis of nanoparticle-treated microglia cells not mixed with any other cell type 
confirmed that microglia avidly took up InGaP/ZnS nanoparticles (Figure 3G). 
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Figure 3. Uptake and subcellular distribution of InGaP/ZnS nanoparticles in primary cortical cultures 
after 4 h of treatment. 
(A-C) Astrocytes were labeled with Abs against GFAP and (D-F) microglia were labeled using Mac-2 
Abs. Scale bar = 20 µm. (G) The uptake of InGaP NPs (10 nM) in microglia N9 after 4 h of treatment as 
assessed by fluorescence-activated cell sorting. All measurements were done in triplicates from three 
independent experiments and the values are expressed as the mean ± standard error of the mean. 
Significant difference when p < 0.01. Nuclei are shown in blue. 
*p < 0.01. 
Ab: Antibody; a.u.: Arbitrary units; GFAP: Glial fibrillary acidic protein; InGaP/ZnS: Indium gallium 
phosphide-zinc sulfide; 
NP: Nanoparticle; RFI: Relative fluorescence intensity. 
Since the high uptake of nanoparticles can cause untoward effects, with the final outcome being 
cell death, we used two different methods to assess if the cell membranes of cells exposed to 
InGaP/ZnS nanoparticles become leaky or cause cells to die. An assessment of plasma 
membrane leakage, using propidium iodide, and cell viability in these primary cortical cultures 
and microglia did not reveal significant cell loss or plasma membrane leakage with up to 10 nM 
concentrations of InGaP/ZnS nanoparticles 1-4 h or 24 h after exposure, but there was 
approximately 5% cell loss measured after 48 h (data not shown). Studies showing a significant 
reduction in cell viability after exposure to CdTe nanoparticles were reported [3,40,45] and 
compared with other nanoparticles [39] . 
To assess the subcellular distribution of InGaP/ZnS nanoparticles in glial cells, vital dyes were 
used for labeling acidic organelles (LysoTracker), mitochondria (MitoTracker) and lipid droplets 
(Bodipy 493/503). A 3D reconstruction of cells from z-stacks and Imaris software were used to 
determine colocalization of nanoparticles with organelles by determining the volume overlaps 
between the nanoparticles and organelles. Colocalization of two labels means that the two signals 
are close enough that they cannot be resolved optically. The Imaris colocalization module 
permits the analysis of the entire confocal stack by measuring the intensity of each label within 
each voxel. The program uses an iterative procedure to determine an intensity threshold of the 
dynamic range (0-255 scale of pixel intensity) for each of the two labels [38] . The extent of 
colocalization is expressed by 'percentage of material colocalized' or 'relative volume overlap' 
(RVO), given by the equation, where SAi is the intensity of the ith voxel for label 
A, i &epsilon;coloc are the voxels of label A with colocalization with label B, 
and i &epsilon;objectAare the voxels above threshold for label A. 
[Formula omitted] 
The data gathered from this equation produce a colocalization measure for each of the labels. 
The advantage of this approach is that it takes into account the number of voxels with 
colocalization as well as the intensities ('immuno-data') of the two labels in each voxel. A 
representative picture of multicolor-labeled organelles in primary cortical cultures exposed to 
InGaP/ZnS nanoparticles and quantification of volumes occupied by the nanoparticles is shown 
(Figure 4). A total of six fields (20-30 cells) were analyzed for each paradigm. An assessment for 
the RVO indicated that the colocalization of InGaP/ZnS nanoparticles with mitochondria was 
very low (less than 2%), Pearce coefficient was 0.003, whereas the colocalization with acidic 
compartments was significantly higher (five- to sixfold higher than in mitochondria; Figure 4J, 
middle bar). There was a significant increase in the number of InGaP/ZnS nanoparticles in 
lysosomes after oleic acid treatment from 17% to 58%, Pearce coefficient 0.41. Also, there was 
an increase in colocalization of InGaP/ZnS nanoparticles to lipid droplets after oleic acid 
treatment from 13% to 46%, Pearce coefficient 0.3. Lipid droplets, organelles not previously 
explored as a subcellular interaction site with nanoparticles, showed small but significantly 
higher colocalization than mitochondria in astrocytes and microglia (Figure 4G-I and lipid 
droplets bar, Figure 4J). 
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Figure 4. Multiple organelle labeling and subcellular location of InGaP/ZnS NPs in live primary cortical 
cells. 
Confocal images showing organelles stained with vital dyes for MT (MitoTracker Green FM, 0.5 µM; 3 
min; A & C ); lysosomes (LysoTracker green-DND 26, 0.5 µM, D & F ); LDs (Bodipy 493/503, 0.01 
mg/ml, 3 min, G & I ) and InGaP/ZnS NPs (10 nM, B,E & H ). An overlay of individual organelles with 
InGaP/ZnS NPs are shown in ( C,F & I ). Panel (J) at the bottom shows mean values and STDs for the 
RVO between the organelles (MT, Lyso, LDs) and InGaP NPs from triplicate measurements in three 
independent experiments. RVO of InGaP/ZnS NPs with lysosomes was significantly larger (p < 0.05) 
than in MT or LDs (J) . 
InGaP/ZnS: Intraorganelle distribution of indium gallium phosphide-zinc sulfide; LD: Lipid droplet; 
Lyso: Acidic organelles; MT: Mitochondria; NP: Nanoparticle; RVO: Relative volume overlap; STD: 
Standard deviation. 
We next studied whether cotreatment with oleic acid, a fatty acid well known for inducing lipid 
droplets in many cell types, would affect the uptake and distribution of InGaP/ZnS 
nanoparticles [22,46] . 
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Figure 5. OA treatment of primary cortical mixed-cell cultures and microglia enhances 
InGaP/ZnS nanoparticle uptake and promotes their colocalization with lipid droplets and 
lysosomes. 
(A) Uptake of InGaP/ZnS nanoparticles in microglia. Ordinate: RFI. A minimum of 5000 cells 
were analyzed (in triplicate) for each condition (two independent experiments) for uptake 
experiments using fluorescence-activated cell sorting analysis. (B & C) Confocal images of 
mitochondria, (D & E) lysosomes and (F & G) lipid droplets before and after OA treatment. (H-
J) show quantitative data from confocal microscopy. The determination of RVO used using 
Imaris software. Changes were considered significant when p < 0.05. 
*p < 0.05. 
a.u.: Arbitrary units; Ctrl: Control; InGaP/ZnS: Intraorganelle distribution of indium gallium 
phosphide-zinc sulfide; OA: Oleic acid; RFI: Relative fluorescence intensity; RVO: Relative 
volume overlaps; STD: Standard deviation. 
Oleic acid treatment (400 µM, 24 h) induced lipid droplet formation in primary cortical cells. 
Cell sorting analysis showed that oleic acid-treated cells internalize significantly larger quantities 
of InGaP/ZnS nanoparticles than the untreated cells (Figure 5A). To assess the intracellular 
location of nanoparticles in cells exposed or unexposed for 24 h to oleic acid, confocal 
microscopy was performed. Confocal images of mitochondria (Figures 5B & C), lysosomes 
(Figures 5D & E) and lipid droplets (Figurse 5F & G) show that the most marked effects of oleic 
acid are seen within cells labeled with Bodipy 493/503, indicating the presence of lipid droplets. 
Determination of organelle volumes and their overlaps with volumes of InGaP/ZnS nanoparticles 
in cells without and with oleic acid treatment show significant differences (Figures 5H & J). The 
bar graphs show the mean values and standard deviations for the RVO from triplicate 
measurements in three independent experiments for mitochondria, lysosomes and lipid droplets. 
Oleic acid did not change the RVO significantly for InGaP/ZnS in mitochondria, (Figure 5H) but 
there was a significant increase in the RVO between nanoparticles and lysosomes (Figure 5I) 
after oleic acid treatment (400 µm, 24 h). Also, oleic acid significantly enhanced the RVO 
between lipid droplets (Figure 5J) and InGaP/ZnS nanoparticles. 
Lavado and coworkers reported that the addition of oleic acid modified the uptake of glucose in 
cultured rat astrocytes [47] , and others demonstrated significant acidic drug penetration through 
the skin by long-chain unsaturated fatty acids (i.e., oleic acid). It is possible that the enhanced 
uptake of InGaP/ZnS nanoparticles by microglia treated with oleic acid reported here could be 
attributed to their amphiphylic character-modifying quantum-dot hydrophobicity. Alternatively, 
oleic acid may potentially disrupt and increase the fluidity of the lipid packing in the cell 
membrane, due to its kinked structure arising from the cis double bond, and hence decrease the 
diffusional resistance to permeants[48] . Recent studies by Khatchadourian et al. showed that oleic 
acid treatment can temporarily increase PC12 cell viability under starvation conditions by 
providing fuel and reducing the extent of oxidative stress caused by cadmium telluride 
nanoparticles [42] . Further internalization and subcellular distribution studies are warranted to 
better understand the mechanism behind the oleic acid enhancement of internalization effects and 
modulation of cellular functions in cells from the CNS. 
InGaP/ZnS nanoparticles were previously studied in proximal renal porcine tubule cell line LLC-
PK-1 and in rat PC12 cells but not in glial cells[7,8] . In these previous studies InGaP/ZnS 
nanoparticles were found to be less toxic than CdSe nanoparticles in nanomolar 
concentrations[7,8] . Several recent reports show that bionanoparticles and artificial nanoparticles 
can enter brain tissue [26,49-54] , therefore excessive uptake of nanoparticles and distribution in cell 
organelles as in glia may have adverse effects on the functions of these and neighboring cells. 
Microglia and astrocytes respond to nanoparticles even if they are exposed to minute quantities 
of nanoparticles, barely or not even detectable by common biochemical or biophysical means. 
We have previously demonstrated that the degree of activation of astrocytes was directly related 
to the physicochemical properties of tested nanoparticles and it was clear that luminescent 
nanoparticles with reactive and unprotected surfaces markedly activated astrocytes at the site of 
administration [28] . However, PEGylated CdSe nanoparticles induced only a small and transient 
activity of astrocytes surrounding the injection site [31] . It was difficult to obtain a more detailed 
subcellular distribution pattern from fixed tissue slices and, therefore, in the present study we 
explored InGaP/ZnS-nanoparticle distribution in living cell organelles using vital dyes. Data 
from confocal micrographs demonstrate that nanoparticles made of type III/V elements (indium 
and gallium) were distributed within several organelles in primary cortical cultures. 
Among the best-known distribution studies with nanoparticles are those with gold nanoparticles, 
because their shapes, sizes and high density allow for detailed analysis using an electron 
microscope (EM) [55] . Nanoparticles can be seen using an EM in fixed cells and are readily 
detected in living cells by fluorescence microscopy. However, optically degenerate nanoparticles 
require silver staining for direct visualization in biological samples under bright-field 
microscopy [56] . Fluorescence studies of nanoparticles in living cells are complementary to EM 
studies. An advantage of the approach illustrated here is that 3D reconstructions from z-stacks 
(from living cells) avoid potential artifacts owing to the inevitable cell fixation necessary for 
preparation of EM samples. 
The common fatty acid, oleic acid, is widely explored as one of the omega-9 fatty acids playing a 
role in development, differentiation and death of neural and other cells [57,58] . The present study 
demonstrates that oleic acid induces lipid droplet formation and enhances the distribution of 
nanoparticles within glial cells (Figure 6). This finding is relevant to studies aimed at the 
application of nanoparticles for medical purposes. 
FIGURE 6 IS OMITTED FROM THIS FORMATTED DOCUMENT 
Figure 6. Changes in InGaP/ZnS nanoparticle uptake and distribution in glial cells without and 
with oleic acid treatment. 
InGaP/ZnS: Indium gallium phosphide-zinc sulfide; QD: Quantum dot. 
Although levels of free fatty acids are strictly controlled in the body, there are circumstances 
when they are elevated or very high [59] . Under normal physiological conditions, they will be 
high during periods of fasting (overnight fast); otherwise, persistently elevated levels of free fatty 
acids are a sign of metabolic problems or disease such as obesity or diabetes [59] . Thus, the 
metabolic status of the organism has to be taken into consideration when testing various 
nanoparticles for their distribution, and their potential hazard or benefit. Further studies are 
needed in single cells and whole animals to better understand effects of fatty acids on uptake and 
distribution of nanoparticles. 
Lipid droplets induced by oleic acid treatment may facilitate subcellular redistribution of 
nanoparticles and change interorganelle communication. Examples of functional interaction 
between lipid droplets and other organelles have been previously reported [60] . It was shown that 
lipid droplets are frequently seen in close proximity (6-10 nm) to mitochondria in porcine 
oocytes, as revealed by fluorescence resonance energy-transfer analyses. The authors have 
postulated that lipid droplets are an important source of energy substrate for the developing 
oocytes [61] . We have also observed a change in interorganelle communication between lipid 
droplets and lysosomes in PC12 cells treated with or without oleic acid. This change in 
interorganelle communication resulted in changes in cell viability [42] . The interaction between 
lipid droplets and other cellular organelles is a new area of research relevant to biological 
applications of nanoparticles. 
The oleic acid augmentation of nanoparticle colocalization with lipid droplets could be 
interesting in many aspects of cell biology and animal studies, because disturbed lipid 
distribution and metabolism is associated with and/or casually related to numerous 
pathologies [62] . Thus, distribution of nanoparticles could be affected in normal and pathological 
states where lipid composition is altered. In addition, abnormalities in endogenous lipid 
distribution and intake of high-fat diets could considerably change nanoparticle cellular and 
tissue biodistribution, resulting in altered cellular functions. 
Conclusion 
InGaP/ZnS nanoparticles are taken up by glial cells of the CNS. Their subcellular distribution is 
altered within the organelles in the presence of oleic acid, which induces lipid droplet formation. 
Oleic acid treatment markedly enhances InGaP/ZnS-nanoparticle internalization and promotes 
colocalization with lipid droplets in glial cells. Since oleic acid and other fatty acids are common 
constituents of food, they could also alter internalization and organelle distribution of other 
nanoparticles, ultimately affecting cellular functions. 
Future perspective 
Fluorescent nanoparticles, particularly those emitting in the far red and infra-red spectral regions, 
are increasingly being used to investigate the interactions between cells and nanoparticles, in 
addition to the fate of nanoparticles in different tissues. This study demonstrates that oleic acid, 
an omega-9 fatty acid, induces lipid droplet formation in glial cells, resulting in the recruitment 
of nanoparticles and a change in the subcellular distribution of this organelle. Treatment of 
neural cells with oleic acid enhances the internalization of nanoparticles by glial cells, especially 
by microglia. Further studies should be carried out to understand the mechanisms involved in 
fatty acid promotion of nanoparticle entry into cells and how they alter cellular functions. Since 
lipid droplets interact with other organelles, these interactions could be disturbed under 
pathological conditions, ultimately affecting nanoparticle fate. Future in vivo studies will 
demonstrate if and how nanoparticle fate is altered in animal models of different diseases (e.g., 
metabolic syndrome and diabetes) so that better imaging systems can be designed as diagnostics 
and drug carriers for therapeutic interventions in states of disturbed metabolism. 
Table 1. Properties of nanoparticles. 
Core 
material 
ZnS-
coated 
Surface 
polymer 
Size 
(nm) 
Surface 
charge 
&lambda;ex(nm) &lambda;em(nm) 
CdTe No None 2.8 Negative <400 535 
CdSe Yes None 4.3 Negative <400 595 
CdSe Yes PEG 18-20 Neutral <400 705 
InGaP Yes None 5.0 Negative <400 680 
InGaP 
(Evident 
Tech) 
Yes PEG-COOH 18-20 Negative <400 703 
&lambda;ex : Wavelength excitation; &lambda;em : Emission wavelength; CdSe: Cadmium 
selenide; CdTe: Cadium teluride; InGaP: Indium gallium phosphide; PEG: Polyethylene glycol; 
ZnS: Zinc sulfide. 
Executive summary 
Indium gallium phosphide-zinc sulfide nanoparticles for real-time imaging 
* Indium gallium phosphide-zinc sulfide (InGaP/ZnS)-coated nanoparticles are higly 
luminescent (Emax = 680 nm) and compare favorably to CdSe/ZnS nanoparticles. 
* They are suitable for both single-cell and whole-animal imaging in real-time. 
Subcellular distribution of InGaP/ZnS nanoparticles in organelles 
* Multicolor imaging of organelles in living neural cells treated with InGaP/ZnS nanoparticles 
reveal their distribution in several organelles, including lipid droplets and acidic organelles. 
Effect of oleic acid treatment on uptake & subcellular distribution of InGaP/ZnS 
nanoparticles 
* Uptake of InGaP/ZnS nanoparticles is significantly enhanced in cells treated with an 
unsaturated omega-9 fatty acid, that is, oleic acid. 
* Oleic acid treatment induces lipid droplet formation in cortical cultures. 
* Lipid droplet induction by oleic acid treatment causes subcellular redistribution of 
nanoparticles and changes i nterorganelle communication. 
* Enhancement of InGaP/ZnS uptake could be attributed to the ability of oleic acid to modify the 
hydrophobicity of nanoparticles and the formation of lipid droplets in cells. 
* The current study suggests that nanoparticle subcellular distribution will be affected by 
different intra- and extra-cellular contents of unsaturated fatty acids. 
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